These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38216306)

  • 1. Recommendations on the Use of Multiple Labels in Human Mass Balance Studies.
    Cuyckens F; Hvenegaard MG; Cassidy KC; Spracklin DK; James AD; Pedersen ML; Scarfe G; Wagner DS; Georgi K; Schulz SI; Schieferstein H; Bjornsdottir I; Romeo AA; Da Violante G; Blech S; Moliner P; Young GC
    Drug Metab Dispos; 2024 Feb; 52(3):153-158. PubMed ID: 38216306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the objective of the mass balance study? A retrospective analysis of data in animal and human excretion studies employing radiolabeled drugs.
    Roffey SJ; Obach RS; Gedge JI; Smith DA
    Drug Metab Rev; 2007; 39(1):17-43. PubMed ID: 17364879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiolabeled absorption, distribution, metabolism, and excretion studies in drug development: why, when, and how?
    Penner N; Xu L; Prakash C
    Chem Res Toxicol; 2012 Mar; 25(3):513-31. PubMed ID: 22309195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications for Metabolite Quantification by Mass Spectrometry in the Absence of Authentic Standards.
    Hatsis P; Waters NJ; Argikar UA
    Drug Metab Dispos; 2017 May; 45(5):492-496. PubMed ID: 28254953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the Pharmacokinetics and Mass Balance of a Single Oral Dose of Trofinetide in Healthy Male Subjects.
    Darwish M; Nunez R; Youakim JM; Robertson P
    Clin Drug Investig; 2024 Jan; 44(1):21-33. PubMed ID: 38017349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabelled mass-balance excretion and metabolism studies in laboratory animals: are they still necessary?
    Obach RS; Nedderman AN; Smith DA
    Xenobiotica; 2012 Jan; 42(1):46-56. PubMed ID: 21992031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human radiolabeled mass balance studies: objectives, utilities and limitations.
    Penner N; Klunk LJ; Prakash C
    Biopharm Drug Dispos; 2009 May; 30(4):185-203. PubMed ID: 19544285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are Biotransformation Studies of Therapeutic Proteins Needed? Scientific Considerations and Technical Challenges.
    Schadt S; Hauri S; Lopes F; Edelmann MR; Staack RF; Villaseñor R; Kettenberger H; Roth AB; Schuler F; Richter WF; Funk C
    Drug Metab Dispos; 2019 Dec; 47(12):1443-1456. PubMed ID: 31748266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of radiolabeled compounds in drug metabolism and pharmacokinetic studies.
    Isin EM; Elmore CS; Nilsson GN; Thompson RA; Weidolf L
    Chem Res Toxicol; 2012 Mar; 25(3):532-42. PubMed ID: 22372867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]tofogliflozin after oral administration and concomitant intravenous microdose administration of [13C]tofogliflozin in humans.
    Schwab D; Portron A; Backholer Z; Lausecker B; Kawashima K
    Clin Pharmacokinet; 2013 Jun; 52(6):463-73. PubMed ID: 23494983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual Biotransformation Reactions of Drugs and Drug Candidates.
    Isin EM
    Drug Metab Dispos; 2023 Apr; 51(4):413-426. PubMed ID: 36653118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid liquid chromatography with tandem mass spectrometry-based screening procedures for studies on the biotransformation of drug candidates.
    Fernández-Metzler CL; Owens KG; Baillie TA; King RC
    Drug Metab Dispos; 1999 Jan; 27(1):32-40. PubMed ID: 10068285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Clinical Absorption, Distribution, Metabolism, and Excretion and Pharmacokinetics of Velsecorat Using an Intravenous Microtracer Combined with an Inhaled Dose in Healthy Subjects.
    Holmberg AA; Weidolf L; Necander S; Bold P; Sidhu S; Pelay-Gimeno M; de Ligt RAF; Verheij ER; Jauhiainen A; Psallidas I; Wählby Hamrén U; Prothon S
    Drug Metab Dispos; 2022 Feb; 50(2):150-157. PubMed ID: 34853068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The area under the curve of metabolites for drugs and metabolites cleared by the liver and extrahepatic organs. Its dependence on the administration route of precursor drug.
    Klippert PJ; Noordhoek J
    Drug Metab Dispos; 1985; 13(1):97-101. PubMed ID: 2858385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional and novel approaches in generating and characterization of reactive intermediates from drugs/drug candidates.
    Orhan H; Vermeulen NP
    Curr Drug Metab; 2011 May; 12(4):383-94. PubMed ID: 21395525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPLC/ICP-MS in combination with "reverse" online isotope dilution in drug metabolism studies.
    Meermann B; Hulstaert A; Laenen A; Van Looveren C; Vliegen M; Cuyckens F; Vanhaecke F
    Anal Chem; 2012 Mar; 84(5):2395-401. PubMed ID: 22304524
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.